The program for the 2018 ICPAD will consist of the following session topics. Please click on the preliminary agenda below to view the preliminary program and confirmed speakers. The information is subject to change.



Session topics

  • Pharmacological challenges of immunotherapeutics
  • Dose individualization approaches
  • Combination therapy – old school is becoming a new school again
  • Drug-Drug / Drug-Food / Drug-Environmental interactions
  • Approaches to shorten phase II studies by the use of different readout endpoints
  • PK/PD studies and new strategies

Confirmed speakers

Dr. Joseph Ciccolini | Aix-Marseille Université, France
Dr. Jean-Pierre Delord | IUCT Oncopole, France
Dr. Alwin Huitema | NKI, the Netherlands
Dr. Markus Joerger | St.Gallen Cancer Center, Switzerland
Dr. Patricia LoRusso | Yale Cancer Center, USA
Dr. Ron Mathijssen | Erasmus Medical Centre, the Netherlands
Dr. Josep María Piulats | Institut Català d’Oncologia, Barcelona, Spain
Dr. Michelle Rudek | Johns Hopkins University School of Medicine, USA
Dr. Ron van Schaik | Erasmus Medical Centre, the Netherlands
Dr. Michel Tod | Faculté de Médecine Lyon-Sud, Université Lyon, France
Dr. Henk Verheul | VU University Medical Centre, the Netherlands